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Abstract: The associations between visceral adiposity index (VAI), body shape index and diabetes in
adults were inconsistent. We assessed the predictive capacity of VAI and body shape index for diabetes
by comparing them with body mass index (BMI) and waist circumference (WC). We used the data of
5838 Chinese men and women aged ≥18 years from the 2009 China Health and Nutrition Survey.
Multivariate logistic regression analysis was performed to examine the independent associations
between Chinese VAI (CVAI) or body shape index and diabetes. The predictive power of the two
indices was assessed using the receiver-operating characteristic (ROC) curve analysis, and compared
with those of BMI and WC. Both CVAI and body shape index were positively associated with diabetes.
The odds ratios for diabetes were 4.9 (2.9–8.1) and 1.8 (1.2–2.8) in men, and 14.2 (5.3–38.2) and 2.0
(1.3–3.1) in women for the highest quartile of CVAI and body shape index, respectively. The area
under the ROC (AUC) and Youden index for CVAI was the highest among all four obesity indicators,
whereas BMI and WC are better indicators for diabetes screening. Higher CVAI and body shape
index scores are independently associated with diabetes risk. CVAI has a higher overall diabetes
diagnostic ability than BMI, WC and body shape index in Chinese adults. BMI and WC, however,
are more appealing as screening indicators considering their easy use.
Keywords: obesity; visceral adiposity index; body shape index; waist circumference; body mass
index; diabetes mellitus
1. Introduction
Diabetes mellitus (DM) has become a major worldwide public health burden in the past decade,
especially in developing countries [1]. The China national Diabetes and Metabolic Disorders Study reported
prevalence of diabetes was 9.7% among adults in 2010 [2,3]. This increased trend of DM is concurrent with
rising rate of obesity in China, and excessive body fat has been proven to be a crucial pathogenic factor for
insulin resistance [4]. Excessive body fat disposed in the ectopic tissue, such as visceral adiposity tissue
(VAT), may cause dysfunctional adiposity and it plays a vicious role in metabolic diseases [5]. In addition,
body fat distribution is related to metabolic disturbances and metabolic disorders [6]. Thus, knowing the
ability to predict the visceral adiposity index for diabetes risk is greatly needed.
Body mass index (BMI), widely used since the early 1990s worldwide for classifying overweight
and obesity, as well as studying obesity associated risks, provides reliable information concerning body
weight excess, but does not differentiate fat from lean mass [7–9]. Waist circumference (WC) is a simple
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anthropometric parameter for abdominal adiposity and it reflects visceral obesity better than BMI [10].
It is a better indicator of obesity associated risks for DM, as shown by our research [11,12], though it has
limitations in distinguishing VAT from subcutaneous fat mass [13]. The magnetic resonance imaging
(MRI) and computed tomography (CT) are considered the gold standard for body fat determination,
but they were less recommended in routine clinical practice due to their unavailability.
The VAI, which is comprised of anthropometric measures like BMI, WC and clinical measures of
serum triglycerides (TG) and high-density lipoprotein-cholesterol (HDL-C) levels, was shown to be a better
surrogate index than these single anthropometric indices in predicting insulin resistant-related metabolic
disorders [14,15]. However, evaluating the predicting performance of VAI, which was developed for
Caucasians, on people who have diabetes in Chinese population may lead to inaccurate results [16,17].
Meanwhile, a body shape index (ABSI), which encompasses waist circumference and BMI, particularly
depicts fat distribution [18,19], and was shown to be a reliable index of body fat accumulation. However,
there is little research on this in China [20].
Therefore, we hypothesize that non-invasive, clinically measurable surrogates could be useful in
identifying body fat distribution and help predict diabetes risk. We aim to examine the associations
between these two indicators and diabetes risk, and to investigate their performance in identifying
diabetes compared with BMI and WC in Chinese adults.
2. Materials and Methods
2.1. Study Design and Population
Data collected in the 2009 China Health and Nutrition Survey (CHNS) was used in this study.
The CHNS is an ongoing, open, multipurpose household based cohort study since 1989. It adapts
a multistage random-cluster sampling process and is conducted in 9 provinces (Liaoning, Heilongjiang,
Shandong, Jiangsu, Henan, Hubei, Hunan, Guangxi and Guizhou), which covers approximately 56%
of China’s population. It was designed to represent a large set of the population, varying significantly
in geography, economic development, public resources and health status. More detailed information
about the CHNS has been described elsewhere [21]. The CHNS was approved by the institutional review
committee of the University of North Carolina at Chapel Hill and Chinese Center for Disease Control and
Prevention. All participants were required to provide written informed consents before their participation.
Using CHNS data, we assessed the associations between the two indicators and diabetes risk,
since fasting blood samples were collected initially in 2009 and the biochemical data collected in
2015 is unavailable currently. A structured questionnaire was used to obtain information on sex,
age and lifestyle behaviors. Participants aged ≥18 years and without missing information on physical
examination and biochemical measurements were included. Exclusion criteria included pregnancy and
no information on age, sex and lifestyle behavior indicators. Ultimately, a total number of 5838 adults
with anthropometry and clinical examination information were included in the analysis (Figure S1).
2.2. Definition of Key Study Outcome DM
DM was defined as having FPG ≥ 7.0 mmol/L, HbA1c ≥ 6.5%, previous diagnosis of DM, or use
of antidiabetic medications. Of the 5838 subjects, 482 (8.3%) had DM.
2.3. Anthropometry and Biochemical Measurements
Weight (kg) and height (m) were measured according to standard methods, and body mass index
(BMI) was calculated as weight/height squared (kg/m2). WC was measured to the nearest 0.1 cm at the
middle point between the bottom of the rib cage and the uppermost border of the iliac crests at the end
of exhalation in standing positions with an inelastic tape. Standard mercury sphygmomanometers
were used to measure blood pressure by trained investigator at three different consecutive times at
3–5 min intervals on one visit. All physical examinations were performed following the same protocol
at each study visit and study site.
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2.4. Biochemical Measurements
Blood was collected from the participants after an at least 8 h overnight fast. The whole blood
was centrifuged immediately after collection, and plasma and serum samples were then frozen and
stored at −87 ◦C for future analysis. Samples for fasting plasma glucose (FPG) and glycated hemoglobin
(HbA1c) measurements were tested immediately. Serum glucose was measured by the glucose oxidase
phenol 4-aminoantipyrine peroxidase (GOD-PAP) methods with a Hitachi 7600 analyzer (Hitachi, Tokyo,
Japan). Whole blood HbA1c was measured with a high-performance liquid chromatography system
(model HLC-723 G7, Tosoh Corporation, Tokyo, Japan). Fasting insulin concentration was tested using
the radioimmunology assay (Gamma counter XH-6020, Xi’an, China). Lipids including total cholesterol
(TC), Total triglycerides (TG), low-density lipoprotein cholesterol (LDL-C) and HDL-C, as well as uric
acid, were measured using a biochemical auto-analyzer (Hitachi 7600 automated analyzer, Tokyo, Japan).
Hypersensitive C-reactive protein (hs-CRP) was determined by the immunoturbidimetric method.
The VAI score was calculated using the specific formula for Chinese population [22]:
Males: CVAI = −267.93 + 0.68 × age + 0.03 × BMI + 4.00 × WC + 22.00 × log10(TG) − 16.32 × HDL
Females: CVAI = −187.32 + 1.71 × age + 4.23 × BMI + 1.12 × WC + 39.76 × log10(TG) − 11.66 × HDL.
ABSI was calculated as WC/(BMI2/3 × height1/2) and expressed in m11/6kg−2/3 [19]. The homeostasis
model assessment of insulin resistance (HOMA-IR) was estimated as HOMA-IR = Fasting glucose
(mmol/L) × fasting insulin (µIU/mL)/22.5 [23].
2.5. Statistical Analysis
Descriptive analyses were presented on the basis of gender-specific quartiles of CVAI and ABSI
scores in order to control for the well-known sexual dimorphism in body composition. The characteristics
were presented as mean (SD) and median with interquartile range (25–75%) given in parentheses
for normalized continuous and skewed variables. Categorical variables were expressed as numbers
and percentages. One-way analysis of variance (ANOVA) or the Mann–Whitney U-test was used for
comparisons of quantitative variables among groups. Chi-squared test was performed to assess differences
in proportions across groups. Partial correlations between two anthropometric indices and metabolic
parameters adjusting for age and sex were evaluated with Pearson’s/Spearman’s correlation analysis.
Multivariable logistic regression models were performed to estimate the odds ratios (ORs) and
95% confident interval (95% CI) of DM associated with these two indices in four models for men and
women, respectively. Receiver operating characteristic (ROC) curve analyses were used to compare
the diagnostic performance of CVAI and ABSI as compared with BMI and WC for DM risk. A user
written command cutpt was used to calculate the Youden index [24,25].
All statistical analyses were conducted using Stata software (version 15.0). A two-tailed statistical
measure was used with a p-value of less than 0.05 is considered significant.
3. Results
3.1. Characteristics of the Study Population Classified According to the CVAI Quartiles
Subject characteristics are shown in Table 1. For both men and women, there were significant
dose-response relationships of CVAI with all variables including clinical indicators and anthropometry
indices (p < 0.001), with the exception of current drinking. A higher proportion of current smoking was
found in women with higher CVAI, whereas the proportion decreased in men. HDL-C was inversely
associated with elevated CVAI scores in men and women (both p < 0.001). The proportion of both men
and women increased progressively with increasing CVAI scores.
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Table 1. Demographic and clinical characteristics of study participants (n = 5838) across Chinese visceral adiposity index (CVAI) quartiles in China.
Men Women
Q1(<57) Q2(57–89) Q3(89–122) Q4(≥122) p-Value Q1(<48) Q2(48–79) Q3(79–109) Q4(≥109) p-Value
n = 623 n = 606 n = 621 n = 613 n = 838 n = 851 n = 828 n = 858
Age, years 49.2 (15.7) 52.6 (13.8) 55.6 (12.9) 56.6 (12.7) <0.001 36.3 (9.9) 49.0 (10.4) 56.0 (10.9) 63.6 (10.5) <0.001
BMI, Kg/m2 20.7 (7.3) 22.6 (2.8) 24.2 (2.6) 27.3 (3.8) <0.001 20.6 (2.2) 22.4 (2.5) 24.2 (2.8) 26.7 (3.5) <0.001
SBP, mm Hg 121.1 (16.3) 125.3 (16.0) 128.9 (17.5) 134.4 (18.5) <0.001 109.8 (12.0) 120.4 (15.8) 127.6 (19.4) 136.8 (20.0) <0.001
DBP, mm Hg 77.7 (10.4) 80.3 (10.2) 82.8 (10.6) 86.7 (10.8) <0.001 72.4 (8.6) 77.8 (9.7) 80.8 (11.2) 83.8 (11.5) <0.001
WC, cm 72.7 (5.9) 81.6 (3.4) 87.8 (3.3) 97.8 (5.8) <0.001 72.1 (7.0) 78.8 (6.7) 84.0 (7.2) 92.0 (8.7) <0.001
WHtR 0.45 (0.06) 0.49 (0.02) 0.53 (0.02) 0.58 (0.03) <0.001 0.46 (0.04) 0.51 (0.04) 0.54 (0.04) 0.60 (0.06) <0.001
WHR 0.83 (0.06) 0.88 (0.05) 0.91 (0.05) 0.95 (0.06) <0.001 0.81 (0.06) 0.86 (0.10) 0.89 (0.10) 0.92 (0.26) <0.001
TC mmol/L 4.6 (0.9) 4.8 (0.9) 4.9 (1.0) 5.1 (1.0) <0.001 4.4 (0.9) 4.9 (1.0) 5.1 (1.0) 5.4 (1.0) <0.001
Total triglycerides,
mmol/L 0.9 (0.7–1.3) 1.2 (0.8–1.8) 1.5 (1.0–2.2) 2.1 (1.4–3.1) <0.001 0.8 (0.6–1.1) 1.1 (0.8–1.6) 1.4 (1.0–1.9) 2.0 (1.4–2.8) <0.001
HDL-C, mmol/L 1.6 (0.5) 1.4 (0.4) 1.3 (0.3) 1.2 (0.3) <0.001 1.7 (0.6) 1.5 (0.4) 1.5 (0.3) 1.3 (0.3) <0.001
LDL-C mmol/L 2.8 (1.1) 3.0 (0.8) 3.1 (1.0) 3.1 (1.0) <0.001 2.6 (0.7) 3.1 (0.9) 3.3 (1.0) 3.3 (1.0) <0.001
HbA1c, % 5.4 (0.8) 5.6 (0.9) 5.7 (1.0) 6.0 (1.1) <0.001 5.3 (1.0) 5.5 (0.6) 5.7 (0.8) 6.0 (1.0) <0.001
HbA1c, mmol/L 35.8 (8.5) 37.6 (9.3) 38.6 (10.5) 42.1 (11.7) <0.001 34.4 (10.7) 36.3 (6.8) 38.7 (9.0) 42.4 (11.4) <0.001
Glucose, mmol/L 5.2 (1.2) 5.4 (1.4) 5.6 (1.6) 6.1 (2.1) <0.001 4.9 (0.6) 5.2 (0.9) 5.5 (1.4) 6.0 (1.8) <0.001
Insulin, µU/mL 8.44(6.00–11.87) 9.18(6.44–13.30) 10.90 (7.64–15.09) 13.70 (9.58–20.58) <0.001 8.98 (6.74–12.34) 10.10 (7.28–13.96) 10.87 (7.77–15.70) 13.53 (9.37–20.52) <0.001
HOMA-IR 1.88 (1.27–2.66) 2.12 (1.42–3.11) 2.58 (1.74–3.78) 3.41 (2.28–5.60) <0.001 1.97 (1.41–2.70) 2.27 (1.62–3.20) 2.53 (1.74–3.94) 3.36 (2.18–5.64) <0.001
QUICKI 2.09 (1.99–2.20) 2.11 (2.00–2.22) 2.09 (2.00–2.21) 2.11 (2.01–2.26) 0.015 2.04 (1.95–2.15) 2.07 (1.98–2.17) 2.09 (2.00–2.19) 2.11 (2.01–2.24) <0.001
hs-CRP, mg/L 1.0 (0.0–2.0) 1.0 (0.0–2.0) 1.0 (1.0–3.0) 2.0 (1.0–3.0) <0.001 0.0 (0.0–1.0) 1.0 (0.0–2.0) 1.0 (1.0–3.0) 2.0 (1.0–4.0) <0.001
Uric acid, mg/L 326.2 (89.2) 339.0 (118.7) 357.9 (116.3) 395.8 (119.3) <0.001 230.7 (58.7) 249.2 (67.8) 271.3 (72.2) 314.4 (87.1) <0.001
Current smoking 385 (61.8%) 343 (56.6%) 332 (53.5%) 304 (49.6%) <0.001 5 (0.6%) 18 (2.1%) 29 (3.5%) 43 (5.0%) <0.001
Current drinking 349 (56.0%) 358 (59.1%) 382 (61.5%) 359 (58.6%) 0.27 87 (10.4%) 87 (10.2%) 66 (8.0%) 74 (8.6%) 0.24
DM 21 (3.4%) 43 (7.1%) 58 (9.3%) 118 (19.2%) <0.001 5 (0.6%) 22 (2.6%) 66 (8.0%) 149 (17.4%) <0.001
BMI, body mass index; BP, blood pressure; WHtR, waist-to-height ratio; WHR, waist-to-hip ratio; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol;
HOMA-IR, homeostatic model assessment of insulin resistance; QUICKI, quantitative insulin sensitivity check index; hs-CRP, high sensitivity C reactive protein; DM, diabetes mellitus.
Data are mean (SD) or median (interquartile range), unless otherwise stated.
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3.2. Characteristics of the Study Population Grouped by ABSI Levels
In both genders, subjects with higher ABSI presented with higher waist circumference, blood
pressure, fasting blood glucose and HbA1c (all p < 0.001). There were no significant differences for
HDL-C, blood insulin and the percentages of current smoking and drinking among ABSI quartile
groups in both men and women. Age, BMI, LDL-C and uric acid were gradually increased across
the quartiles in women only. Both men and women had the increased prevalence of diabetes with
increasing quartiles of ABSI scores (Table 2).
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Table 2. Characteristics of participants by body shape index (ABSI) among men and women in China (n = 5838).
Men Women
Q1 Q2 Q3 Q4 p-Value Q1 Q2 Q3 Q4 p-Value
n = 608 n = 544 n = 744 n = 567 n = 899 n = 892 n = 767 n = 817
Age, years 49.3 (14.7) 51.8 (14.0) 53.9 (12.9) 59.1 (13.1) <0.001 44.7 (13.5) 49.1 (13.2) 53.7 (12.8) 58.6 (14.4) <0.001
BMI, Kg/m2 24.0 (8.4) 23.6 (3.4) 24.0 (3.3) 22.9 (3.5) <0.001 23.3 (3.7) 23.7 (3.5) 24.0 (3.4) 23.1 (3.5) <0.001
Systolic BP, mm
Hg 124.2 (16.2) 127.0 (17.5) 129.0 (18.6) 129.2 (18.0) <0.001 117.6 (16.3) 123.6 (20.1) 125.9 (19.9) 128.5 (21.0) <0.001
Diastolic BP, mm
Hg 80.4 (10.9) 81.9 (11.1) 82.5 (11.1) 82.5 (10.9) 0.002 76.3 (9.9) 79.4 (11.7) 79.7 (10.8) 79.8 (11.6) <0.001
Waist
circumference, cm 77.0 (9.3) 83.2 (8.3) 87.8 (8.5) 91.4 (9.3) <0.001 73.5 (8.0) 80.2 (8.4) 84.6 (8.2) 89.8 (9.6) <0.001
WHtR 0.47 (0.07) 0.50 (0.05) 0.53 (0.05) 0.55 (0.05) <0.001 0.47 (0.05) 0.51 (0.05) 0.54 (0.05) 0.58 (0.06) <0.001
WHR 0.84 (0.07) 0.88 (0.05) 0.91 (0.05) 0.95 (0.07) <0.001 0.80 (0.06) 0.85 (0.07) 0.88 (0.05) 0.96 (0.28) <0.001
CVAI 53.3 (41.7) 80.7 (39.4) 102.0 (40.2) 119.9 (42.0) <0.001 54.0 (42.7) 73.8 (41.7) 89.2 (40.0) 99.4 (41.6) <0.001
Total cholesterol,
mmol/L 4.8 (1.0) 4.9 (0.9) 4.9 (1.0) 4.9 (1.0) 0.071 4.7 (1.0) 4.9 (1.0) 5.0 (1.0) 5.2 (1.1) <0.001
Total triglycerides,
mmol/L 1.2 (0.8–1.9) 1.2 (0.8–2.0) 1.4 (0.9–2.2) 1.4 (0.9–2.3) <0.001 1.1 (0.7–1.6) 1.3 (0.8–1.9) 1.3 (0.9–2.1) 1.4 (0.9–2.1) <0.001
HDL-cholesterol,
mmol/L 1.4 (0.4) 1.4 (0.5) 1.4 (0.4) 1.4 (0.4) 0.17 1.5 (0.4) 1.5 (0.4) 1.5 (0.6) 1.5 (0.5) 0.14
LDL-cholesterol,
mmol/L 2.9 (0.9) 3.0 (1.0) 3.0 (1.0) 3.0 (1.1) 0.38 2.9 (0.9) 3.0 (1.0) 3.1 (1.0) 3.2 (1.0) <0.001
HbA1c, % 5.6 (0.9) 5.6 (0.8) 5.7 (0.9) 5.8 (1.1) <0.001 5.5 (0.6) 5.6 (1.1) 5.7 (0.9) 5.8 (1.0) <0.001
HbA1c, mmol/L 37.2 (9.5) 37.8 (8.5) 38.8 (10.1) 40.3 (12.6) <0.001 36.1 (7.0) 37.4 (11.7) 38.7 (9.3) 39.9 (11.2) <0.001
Glucose, mmol/L 5.4 (1.6) 5.5 (1.4) 5.7 (1.8) 5.7 (1.7) <0.001 5.1 (0.9) 5.3 (1.1) 5.5 (1.3) 5.7 (1.9) <0.001
Insulin, µU/mL 10.10 (6.95–14.07) 10.48 (6.97–14.99) 10.52 (7.33–15.14) 10.70 (7.14–15.90) 0.13 10.39 (7.66–14.61) 10.71 (7.58–15.41) 10.61 (7.85–16.15) 10.80 (7.58–15.81) 0.27
HOMA-IR 2.26 (1.50–3.35) 2.44 (1.55–3.68) 2.52 (1.66–3.87) 2.46 (1.63–4.15) 0.006 2.26 (1.64–3.39) 2.42 (1.68–3.69) 2.48 (1.73–3.89) 2.49 (1.65–4.01) 0.003
QUICKI 2.09 (1.98–2.19) 2.10 (2.00–2.22) 2.11 (2.02–2.23) 2.11 (2.00–2.24) 0.018 2.05 (1.96–2.15) 2.08 (1.99–2.17) 2.09 (2.00–2.20) 2.10 (2.01–2.23) <0.001
hs-CRP, mg/L 1.0 (0.0–2.0) 1.0 (0.0–2.0) 1.0 (1.0–3.0) 1.0 (1.0–3.0) <0.001 1.0 (0.0–2.0) 1.0 (0.0–2.0) 1.0 (1.0–3.0) 1.0 (1.0–3.0) <0.001
Uric acid, mg/L 347.3 (127.8) 352.1 (114.8) 364.1 (112.0) 352.7 (100.7) 0.045 253.6 (73.5) 263.9 (78.3) 272.5 (80.3) 278.3 (81.2) <0.001
Current smoking 320 (52.6%) 300 (55.1%) 429 (57.7%) 315 (55.6%) 0.33 19 (2.1%) 14 (1.6%) 26 (3.4%) 36 (4.4%) 0.002
Current drinking 343 (56.4%) 323 (59.4%) 453 (60.9%) 329 (58.0%) 0.39 77 (8.6%) 89 (10.0%) 73 (9.5%) 75 (9.2%) 0.77
DM 38 (6.3%) 43 (7.9%) 82 (11.0%) 77 (13.6%) <0.001 31 (3.4%) 48 (5.4%) 67 (8.7%) 96 (11.8%) <0.001
BMI, body mass index; BP, blood pressure; WHtR, waist-to-height ratio; WHR, waist-to=hip ratio; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol;
HOMA-IR, homeostatic model assessment of insulin resistance; QUICKI, quantitative insulin sensitivity check index; hs-CRP, hypersensitivity C reactive protein; DM, diabetes mellitus.
Data are mean (SD) or median (interquartile range), unless otherwise stated.
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3.3. Partial Correlation Analysis with Metabolic Variables
Table 3 shows CVAI positively correlated with FPG, blood insulin, HbA1c, lipid profiles and
uric acid (all p < 0.001), and negatively with HDL-C after adjusting for age and sex. The correlation
between ASBI and the metabolic indicators showed similar patterns, but the correlation coefficients
were smaller than correlation with CVAI.
Table 3. Correlations of CVAI and ABSI with metabolic variables among adults in China.
CVAI (Age-and Sex Adjusted) ABSI (Age-and Sex Adjusted)
r p r p
Glucose 0.209 <0.001 0.042 0.002
HbA1c (%) 0.199 <0.001 0.044 <0.001
Insulin 0.133 <0.001 0.029 0.03
HOMA-IR 0.144 <0.001 0.035 0.008
TC 0.201 <0.001 0.034 0.009
TG 0.451 <0.001 0.054 <0.001
HDL-C −0.420 <0.001 −0.005 <0.01
LDL-C 0.127 <0.001 0.022 0.09
Uric acid 0.292 <0.001 0.027 0.04
hs-CRP 0.021 0.11 0.012 0.35
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HOMA-IR, homeostatic
model assessment of insulin resistance; hs-CRP, high sensitivity C reactive protein.
3.4. ORs of CVAI or ABSI with Risk of Diabetes
Multivariable logistic regression models showed that the ORs for diabetes increased with elevated
quartiles of the CVAI or ABSI score for both men and women in all four models (Table 4). The independent
association of CVAI or ABSI with diabetes was stronger in women than in men, although the cut-point for
CVAI and ABSI quartiles was higher in men than in women. The age-adjusted associations (OR, 95% CI)
with diabetes for the second, third and fourth CVAI quartiles in men were 2.0 (1.2–3.5), 2.6 (1.5–4.3) and
5.9 (3.6–9.6), in comparison with the first quartile (Model 1). The corresponding figures were 3.6 (1.3–9.7),
10.5 (4.1–27.1) and 22.6 (8.7–58.9) for women, respectively. Significant associations were found for diabetes
with the third and fourth ABSI quartiles in all subjects. These association estimators were basically
unchanged after additionally adjusting for lifestyle behavior factors and economic status (Model 2). After
additional adjusting for blood pressure and inflammatory biomarkers, the OR increased by about 10%
(Model 3 and Model 4).
Table 4. Adjusted odds ratios (ORs) and 95% CI of the visceral adiposity index and body shape index
with diabetes risk in adults in China.
Model 1 Model 2 Model 3 Model 4
Visceral adiposity index (CVAI)
Men
Q1 1 1 1 1
Q2 2.0 (1.2–3.5) 2.0 (1.2–3.5) 2.0 (1.1–3.4) 1.9 (1.1–3.3)
Q3 2.6 (1.5–4.3) 2.6 (1.5–4.3) 2.4 (1.4–4.0) 2.3 (1.4–3.9)
Q4 5.9 (3.6–9.6) 5.9 (3.6–9.5) 5.2 (3.1–8.5)) 4.9 (2.9–8.1)
Women
Q1 1 1 1 1
Q2 3.6 (1.3–9.7) 3.7 (1.4–9.9) 3.1 (1.2–8.4) 3.0 (1.1–8.2)
Q3 10.5 (4.1–27.1) 10.7 (4.1–27.5) 8.7 (3.2–21.7) 7.7 (2.9–21.0)
Q4 22.6 (8.7–58.9) 22.9 (8.8–59.9) 16.2 (6.1–43.2) 14.2 (5.3–38.2)
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Table 4. Cont.
Model 1 Model 2 Model 3 Model 4
Body shape index (ABSI)
Men
Q1 1 1 1 1
Q2 1.2 (0.8–1.9) 1.3 (0.8–2.0) 1.2 (0.8–1.9) 1.2 (0.8–1.9)
Q3 1.7 (1.1–2.5) 1.8 (1.2–2.6) 1.6 (1.1–2.5) 1.6 (1.1–2.4)
Q4 1.9 (1.2–2.8) 1.9 (1.2–2.9) 1.9 (1.2–2.8) 1.8 (1.2–2.8)
Women
Q1 1 1 1 1
Q2 1.3 (0.8–2.1) 1.4 (0.9–2.2) 1.2 (0.8–2.0) 1.2 (0.7–1.9)
Q3 1.9 (1.2–2.9) 1.2 (1.2–3.0) 1.8 (1.1–2.8) 1.7 (1.1–2.7)
Q4 2.0 (1.3–3.1) 2.1 (1.4–3.3) 2.0 (1.3–3.1) 2.0 (1.3–3.1)
Model 1: Adjusted for age; Model 2: Adjusted for age, residence, and smoking and alcohol use; Model 3: Adjusted for
age, residence, smoking and alcohol use, total cholesterol, systolic BP and DBP; Model 4: Adjusted for age, residence,
smoking and alcohol use, total cholesterol, systolic BP, DBP, uric acid and hypersensitive-C reactive protein.
3.5. Receiver-Operating Characteristic (ROC) Curve Analysis and Optimum Thresholds for Anthropometric
Indices
Among all the 4 anthropometric indices, CVAI had the highest AUC values for diabetes in men
(AUC = 0.729, 95% CI 0.696–0.762) and in women (AUC = 0.794, 95% CI 0.767–0.818). ABSI had the
lowest AUC values in both sexes (men: AUC 0.679, 95% CI 0.552–0.721; women: AUC 0.761, 95% CI
0.735–0.787). The diagnostic performance of CVAI is similar with waist circumference in Chinese
subjects (Figure 1). Table 5 shows the sensitivity, specificity and corresponding optimal cut-off values
of each index for identifying diabetes by gender. CVAI had the highest Youden index values for
identifying diabetes in men (0.36) and in women (0.50); the optimal CVAI cut-off was 107.27 in men
and 88.15 in women.
Figure 1. The ROC curves of CVAI, ABSI, BMI and WC for diabetes among men (A) and women (B) in
China. ROC, receiver-operating characteristic; CVAI, Chinese visceral adiposity index; ABSI, a body
shape index; BMI, body mass index; WC, waist circumference; AUCs, area under curves. AUCs were
0.729 and 0.794 for diagnosis of diabetes for men and women, respectively, and this is significantly
better than ABSI, BMI and WC in Chinese adults (All p < 0.01).
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Table 5. Sensitivity, specificity, Youden index and sex-specific cut-off points for various obesity indices













CVAI 107.27 0.65 0.71 0.36 88.15 0.79 0.71 0.50
ABSI 0.08 0.72 0.57 0.28 0.08 0.84 0.57 0.41
BMI 24.73 0.86 0.46 0.32 23.18 0.82 0.63 0.45
WC 87.9 0.71 0.63 0.34 84.9 0.84 0.62 0.46
CVAI, Chinese visceral adiposity index; ABSI, body shape index; BMI, body mass index; WC, waist circumference.
4. Discussion
This study assessed the associations of the Chinese visceral adiposity index (CVAI) and body shape
index (ABSI)—two indicators of adiposity distribution and function—with DM risks among adult
Chinese people. We found graded positive associations of CVAI and ABSI scores with diabetes risks in
both men and women. Partial correlation analysis found that the CVAI and ABSI were independently
related to insulin resistance and lipid profiles. We also showed that the CVAI is superior to ABSI,
BMI and waist circumference in predicting diabetes in both genders.
Increase in the prevalence of obesity and physical inactivity was concurrent with a tripling in
diabetes incidence and other metabolic diseases over the past few decades in China [26]. Of the many
obesity phenotypes, visceral obesity/fat is more metabolically deleterious than general obesity or
subcutaneous fat, and it has been proposed as a marker of adiposity dysfunctional and ectopic fat
deposition, which in turn leads to lipotoxicity and insulin resistance. Given that quantitating visceral
adipose using CT or MRI is not feasible in large cohort studies and daily investigation, some simple
clinical anthropometric indices such as WC and WHtR were used as surrogate indices of visceral
adiposity to identify metabolic diseases. However, these classic anthropometric indices have the
common shortcoming of their inability to take metabolic measures into consideration, and thus are not
robust in various populations.
The present study adopted a developed indicator of visceral adiposity for the Chinese population,
which is reliable for evaluating metabolic risk [27] and highest discriminatory power for dysglycemia
in male and females. Consistent with other studies [22,28], our results showed that the CVAI score
is associated with diabetes risk and is a good clinical index for prediction of visceral fat dysfunction.
The associations of obesity indicators, including BMI and WC, with incident diabetes in multiethnic
populations worldwide have been confirmed by several meta-analysis studies by the significant pooled
estimates of the relative risk [29,30]. In our study, the CVAI score was highly correlated to and behaved
slightly better in diabetes prediction than BMI and WC in Chinese adults by means of a higher AUC
and an overall differentiating ability. Thus, CVAI is a useful clinical obesity indictor for diabetes risk
when biospecimen data are available.
Previously, ABSI was developed base on the US National Health and Nutrition Examination
Survey (NHANES) 1999–2004 data, which included several ethnicities like Mexican, other Hispanic,
white, black, or other. For a given height and weight, ABSI is suitable for reflecting VAT [31]; however,
subsequent research revealed conflicting results regarding its predictability for chronic diseases and
mortality [31–33]. A study conducted in Dutch adults showed that ABSI was not a suitable index to
identify CVD or CVD risk factors [34]. ABSI was not a better predictor of diabetes, hypertension or
dyslipidaemia than WC or BMI in Japanese adults [35]. By contrast, Zhao and colleagues [18] recently
indicated that ABSI had a better predictive ability than BMI in predicting diabetes in Han Chinese
people in Northeast China. In agreement with previous studies [31,36,37], our study indicates that
ABSI may not be a better predictor of diabetes than BMI or WC.
Furthermore, we incorporate types of staple foods into the analysis to examine the reason of
conflicting findings with Zhao et al. People living the North China mainly consume wheat products.
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After re-analyzed the ROC separately by rice/wheat intake, our results showed that ABSI had a better
predictive ability than BMI in men whose staple food is rice (results not reported), which is consistent with
Zhao’s findings that ABSI is better than BMI in predicting diabetes in the Northeast Chinese population.
Interestingly, our study showed that increasing CVAI scores associated stronger with diabetes in
women than men, whereas the ABSI had comparable predicting of diabetes risk in men and women.
The explanations for these issues remain to be elucidated, and this may be related to gender differences
in patterns of visceral fat deposition and regional adipose tissue distribution [38]. The mechanisms by
which visceral adiposity can lead to diabetes may be different in men versus women. Besides, age is
a well-established risk factor for diabetes, and women in the 4th CVAI quartile had a higher age than
men in this group, hence diabetes risk may be partly explained by age and other related unfavorable
traits. We think CVAI and ABSI serve as markers of diabetes risk for both men and women, but women
should pay more attention to their visceral fat deposition.
Our results showed that both CVAI and ABSI indicate close correlations with lipid levels, insulin
resistance and inflammation in both men and women (p < 0.01). In addition, all four anthropometric
indices exhibited the capability to identify individuals with diabetes (all AUC > 0.5 for all), and CVAI
together with ABSI are strong and independent risk factors for diabetes (all ORs > 1). However,
CVAI demonstrated the strongest prediction ability (AUC = 0.729 in men and 0.794 in women) among
all anthropometric indices and ABSI had the weakest association with diabetes risk in both men
and women. This might be because CVAI serve as a strong surrogate marker of visceral adiposity
dysfunction, while ABSI, similar to BMI and WC, does not differentiate excess central adiposity in
Chinese adults. Despite a high AUC value, CVAI has the lowest sensitivity among all the obesity
indicators in both genders. It might not be the best indicator for the screening of diabetes.
The cutoffs for BMI and WC in predicting risk of T2DM in Chinese adults remain controversial.
In response to WHO’s recommendations on the cutoff values for public health action for Asians, the Working
Group on Obesity in China (WGOC) suggested that BMI≥24 signifies overweight in Chinese population [39].
In the present study, the optimal cut-off values for Chinese men and women were found to be approximately
BMI = 25 and 23, and 88.0 and 85.0 cm for WC, respectively. The current recommended cutoffs regarding
central obesity in China are WC ≥ 90 cm for men and WC ≥ 90 for women. Compared with WGOC
definitions and WC recommendations, our data observed a similar cutoff value for WC in women,
but a lower value in men, and a sex difference for BMI. However, these results need be interpreted with
caution because these cutoffs were based on data collected in a sample of 2433 men and 3320 women aged
52 ± 14 from 9 provinces in China.
Our study has several limitations. First, the cross-sectional data analyses cannot make causal
inferences regarding the relationships between CVAI or ABSI and DM risks. Second, no direct measure
of insulin resistance was done, and we were unable to directly assess the association of CVAI/ABSI
with insulin resistance. Third, data on 2 h postprandial glucose was unavailable, which might lead
to the underdiagnoses of some diabetic subjects. Key strengths of the study include that the data set
provide rich related measures and a large sample allows us to assess the various associations and the
predicting power of a set of indices.
5. Conclusions
In conclusion, our study indicated that both CVAI and ABSI are strong and independent risk factors
for diabetes among Chinese adults. Superior to that of the BMI, WC and ABSI, CVAI demonstrates the
best predictive power for metabolic disorders based on the Youden index in both genders. However,
for the diabetes screening purpose, BMI and WC are better indicators than CVAI considering their
higher sensitivity and accessibility and easy use in different settings, including by the public.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/11/7/1580/s1,
Figure S1: Flowchart of selection process for the data included in this analysis.
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